Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 1
2001 3
2002 2
2003 2
2004 3
2005 4
2006 7
2007 3
2008 3
2009 2
2010 7
2011 4
2012 5
2013 2
2014 4
2015 3
2016 7
2017 7
2018 3
2019 6
2020 4
2021 2
2022 5
2023 5
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity.
Sorrentino V, Romani M, Mouchiroud L, Beck JS, Zhang H, D'Amico D, Moullan N, Potenza F, Schmid AW, Rietsch S, Counts SE, Auwerx J. Sorrentino V, et al. Among authors: counts se. Nature. 2017 Dec 14;552(7684):187-193. doi: 10.1038/nature25143. Epub 2017 Dec 6. Nature. 2017. PMID: 29211722 Free PMC article.
Vascular cognitive impairment and dementia.
Gorelick PB, Counts SE, Nyenhuis D. Gorelick PB, et al. Among authors: counts se. Biochim Biophys Acta. 2016 May;1862(5):860-8. doi: 10.1016/j.bbadis.2015.12.015. Epub 2015 Dec 15. Biochim Biophys Acta. 2016. PMID: 26704177 Free PMC article. Review.
Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy.
Kelly L, Brown C, Michalik D, Hawkes CA, Aldea R, Agarwal N, Salib R, Alzetani A, Ethell DW, Counts SE, de Leon M, Fossati S, Koronyo-Hamaoui M, Piazza F, Rich SA, Wolters FJ, Snyder H, Ismail O, Elahi F, Proulx ST, Verma A, Wunderlich H, Haack M, Dodart JC, Mazer N, Carare RO. Kelly L, et al. Among authors: counts se. Alzheimers Dement. 2024 Feb;20(2):1421-1435. doi: 10.1002/alz.13512. Epub 2023 Oct 28. Alzheimers Dement. 2024. PMID: 37897797 Free PMC article. Review.
Multi-Infarct Dementia: A Historical Perspective.
McKay E, Counts SE. McKay E, et al. Among authors: counts se. Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):160-171. doi: 10.1159/000470836. eCollection 2017 Jan-Apr. Dement Geriatr Cogn Dis Extra. 2017. PMID: 28626470 Free PMC article. Review.
Mild cognitive impairment: pathology and mechanisms.
Mufson EJ, Binder L, Counts SE, DeKosky ST, de Toledo-Morrell L, Ginsberg SD, Ikonomovic MD, Perez SE, Scheff SW. Mufson EJ, et al. Among authors: counts se. Acta Neuropathol. 2012 Jan;123(1):13-30. doi: 10.1007/s00401-011-0884-1. Epub 2011 Nov 19. Acta Neuropathol. 2012. PMID: 22101321 Free PMC article. Review.
Oxytocin Receptor Signaling in Vascular Function and Stroke.
McKay EC, Counts SE. McKay EC, et al. Among authors: counts se. Front Neurosci. 2020 Sep 25;14:574499. doi: 10.3389/fnins.2020.574499. eCollection 2020. Front Neurosci. 2020. PMID: 33071746 Free PMC article. Review.
Galanin in Alzheimer disease.
Counts SE, Perez SE, Ginsberg SD, De Lacalle S, Mufson EJ. Counts SE, et al. Mol Interv. 2003 May;3(3):137-56. doi: 10.1124/mi.3.3.137. Mol Interv. 2003. PMID: 14993421 Review.
93 results